<DOC>
	<DOC>NCT00655746</DOC>
	<brief_summary>The purpose of this study is to assess the effect of omeprazole on the pharmacokinetics of dasatinib in healthy subjects and to assess the safety and tolerability of a single dose of dasatinib before and after 5 days of dosing with omeprazole in healthy subjects</brief_summary>
	<brief_title>The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Dasatinib</mesh_term>
	<criteria>Healthy subjects as determined by medical history, physical examination, ECGs, and clinical laboratory determinations Women who are pregnant or breastfeeding Prior exposure to dasatinib</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Healthy Subjects</keyword>
</DOC>